In this case, prostate cancer PC-3 and C4-2B cell-derived EVs are rich in pyruvate kinase muscle isozyme M2 (PKM2) and transfer this protein to bone marrow stem cells (BMSCs). Here, PKM is linked to prostate carcinoma.